Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mine Harada

Showing results (231-240 of 251) with videos related to

Pageof 26
Sort By:
International Journal of Hematology|July 14, 2020
Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studiesNaoyuki Uchida, Kana Matsumoto, Toru Sakura, et al.
Immunology Letters|May 17, 2005
Mitogen-activated protein kinase pathway controls autoimmune regulator (AIRE) gene expression in granulo-monocyte colony stimulating factor (GM-CSF)-stimulated myelomonocytic leukemia OTC-4 cellsSeiho Nagafuchi, Hitoshi Katsuta, Yuju Ohno, et al.
Blood|March 6, 2002
Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient miceKazuya Shimoda, Hiroko Tsutsui, Kenichi Aoki, et al.
International Journal of Hematology|November 26, 2009
Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myelomaKazutaka Sunami, Katsuji Shinagawa, Morio Sawamura, et al.
Experimental Hematology|December 10, 2003
Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of DaxxKenichi Aoki, Kazuya Shimoda, Kenji Oritani, et al.
International Journal of Hematology|September 18, 2008
Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignanciesSung-Won Kim, Keitaro Matsuo, Takahiro Fukuda, et al.
Transfusion|November 8, 2002
Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilizationTeruhiko Kozuka, Kazuma Ikeda, Takanori Teshima, et al.
British Journal of Haematology|August 16, 2005
Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donorsTakanori Teshima, Keitaro Matsuo, Kosei Matsue, et al.
Cell Stem Cell|March 29, 2008
Foxo3a is essential for maintenance of the hematopoietic stem cell poolKana Miyamoto, Kiyomi Y Araki, Kazuhito Naka, et al.
International Journal of Clinical Oncology|April 3, 2019
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)Kazutaka Sunami, Morio Matsumoto, Shin-Ichi Fuchida, et al.
Pageof 26

Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
International Journal of Hematology|July 14, 2020
Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studiesNaoyuki Uchida, Kana Matsumoto, Toru Sakura, et al.
Immunology Letters|May 17, 2005
Mitogen-activated protein kinase pathway controls autoimmune regulator (AIRE) gene expression in granulo-monocyte colony stimulating factor (GM-CSF)-stimulated myelomonocytic leukemia OTC-4 cellsSeiho Nagafuchi, Hitoshi Katsuta, Yuju Ohno, et al.
Blood|March 6, 2002
Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient miceKazuya Shimoda, Hiroko Tsutsui, Kenichi Aoki, et al.
International Journal of Hematology|November 26, 2009
Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myelomaKazutaka Sunami, Katsuji Shinagawa, Morio Sawamura, et al.
Experimental Hematology|December 10, 2003
Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of DaxxKenichi Aoki, Kazuya Shimoda, Kenji Oritani, et al.
International Journal of Hematology|September 18, 2008
Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignanciesSung-Won Kim, Keitaro Matsuo, Takahiro Fukuda, et al.
Transfusion|November 8, 2002
Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilizationTeruhiko Kozuka, Kazuma Ikeda, Takanori Teshima, et al.
British Journal of Haematology|August 16, 2005
Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donorsTakanori Teshima, Keitaro Matsuo, Kosei Matsue, et al.
Cell Stem Cell|March 29, 2008
Foxo3a is essential for maintenance of the hematopoietic stem cell poolKana Miyamoto, Kiyomi Y Araki, Kazuhito Naka, et al.
International Journal of Clinical Oncology|April 3, 2019
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)Kazutaka Sunami, Morio Matsumoto, Shin-Ichi Fuchida, et al.
Pageof 26